Concepedia

Publication | Open Access

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

DOIFull Paper Access

275

Citations

30

References

2014

Year

Thomas Kaley, Patrick Y. Wen, David Schiff, Keith L. Ligon, Sam Haidar, Sasan Karimi, Andrew B. Lassman, Craig Nolan, Lisa M. DeAngelis, Igor T. Gavrilovic,
Neuro-Oncology

Abstract

Sunitinib is active in recurrent atypical/malignant meningioma patients. A randomized trial should be performed.

References

YearCitations

Page 1